A 3D medical illustration of 2019 Coronavirus, Credit: https://www.scientificanimations.com.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

US-based Co-Diagnostics has launched a research use only (RUO) CoPrimer test for new coronavirus (2019-nCoV).

The company launched the product just weeks after it completed principle design work for the test to address the growing need for testing designs to detect the presence of coronavirus.

To date, the coronavirus outbreak killed 638 people, with a total of 31,428 infection cases now confirmed.

The Logix Smart 2019-nCoV coronavirus test is now available for sale to laboratories, hospitals and institutions.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Designed leveraging the company’s CoDx Design software system, the test helps in identifying the most optimal target on the 2019-nCoV genome for a PCR assay.

Co-Diagnostics expects that the test will ensure greater accuracy in detecting the presence of the coronavirus.

Co-Diagnostics CEO Dwight Egan said: “Leveraging our proprietary design process and software has allowed us to quickly move this product from design into commercialisation, and to do so with the confidence that our high-quality product meets our goal of providing an effective, much-needed global diagnostic solution in an emergency situation.”

“As a result of our rapid development, we have already received requests from customers in countries across the world to purchase tests.

“Sales and shipments of products will be fulfilled from our Utah headquarters to customers who have the capacity to utilise RUO products to slow the spread of this epidemic.”

Last week, Novacyt’s molecular diagnostics division Primerdesign launched a molecular RUO test for 2019-nCoV.

Meanwhile, the coronavirus outbreak, which originated from China’s Hubei province, has affected a total of 26 countries.